Viewing Study NCT04632056

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 11:25 PM

Ignite Modification Date: 2025-12-25 @ 9:11 PM

Study NCT ID: NCT04632056

Status: COMPLETED

Last Update Posted: 2023-11-14

First Post: 2020-11-12

Is NOT Gene Therapy: False

Has Adverse Events: False

Brief Title: A 52-weeks Observational Study to Evaluate the Safety of Brolucizumab in Patients With nAMD

Sponsor: Novartis Pharmaceuticals

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module